866-997-4948(US-Canada Toll Free)

Europe Cancer Monoclonal Antibodies Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Cancer

No. of Pages : 115 Pages

Notes:
Sales, means the sales volume of Cancer Monoclonal Antibodies
Revenue, means the sales value of Cancer Monoclonal Antibodies

This report studies sales (consumption) of Cancer Monoclonal Antibodies in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
AstraZeneca
Bayer
Merck
Janssen Biotech
Novartis
OncoMed Pharmaceuticals
Pfizer
Eli Lilly
Sanofi
TG Therapeutics
CTI BioPharma
Intas Pharmaceuticals
Boehringer Ingelheim
Biogen

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Monoclonal Antibodies in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Naked MAbs
Conjugated MAbs

Split by application, this report focuses on sales, market share and growth rate of Cancer Monoclonal Antibodies in each application, can be divided into
Immune System Suppressors
Kill or Inhibit Malignant Cells
Deliver Chemotherapy To Cancer Cells

Table of Contents

Europe Cancer Monoclonal Antibodies Market Report 2017
1 Cancer Monoclonal Antibodies Overview
1.1 Product Overview and Scope of Cancer Monoclonal Antibodies
1.2 Classification of Cancer Monoclonal Antibodies
1.2.1 Naked MAbs
1.2.2 Conjugated MAbs
1.3 Application of Cancer Monoclonal Antibodies
1.3.1 Immune System Suppressors
1.3.2 Kill or Inhibit Malignant Cells
1.3.3 Deliver Chemotherapy To Cancer Cells
1.4 Cancer Monoclonal Antibodies Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Cancer Monoclonal Antibodies (2012-2022)
1.5.1 Europe Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2022)
1.5.2 Europe Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)

2 Europe Cancer Monoclonal Antibodies by Manufacturers, Type and Application
2.1 Europe Cancer Monoclonal Antibodies Market Competition by Manufacturers
2.1.1 Europe Cancer Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Cancer Monoclonal Antibodies Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Monoclonal Antibodies (Volume and Value) by Type
2.2.1 Europe Cancer Monoclonal Antibodies Sales and Market Share by Type (2012-2017)
2.2.2 Europe Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
2.3 Europe Cancer Monoclonal Antibodies (Volume and Value) by Countries
2.3.1 Europe Cancer Monoclonal Antibodies Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Cancer Monoclonal Antibodies Revenue and Market Share by Countries (2012-2017)
2.4 Europe Cancer Monoclonal Antibodies (Volume) by Application

3 Germany Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
3.1 Germany Cancer Monoclonal Antibodies Sales and Value (2012-2017)
3.1.1 Germany Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
3.1.2 Germany Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
3.1.3 Germany Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
3.2 Germany Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
3.3 Germany Cancer Monoclonal Antibodies Sales and Market Share by Type
3.4 Germany Cancer Monoclonal Antibodies Sales and Market Share by Application

4 France Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
4.1 France Cancer Monoclonal Antibodies Sales and Value (2012-2017)
4.1.1 France Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
4.1.2 France Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
4.1.4 France Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
4.2 France Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
4.3 France Cancer Monoclonal Antibodies Sales and Market Share by Type
4.4 France Cancer Monoclonal Antibodies Sales and Market Share by Application

5 UK Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
5.1 UK Cancer Monoclonal Antibodies Sales and Value (2012-2017)
5.1.1 UK Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
5.1.2 UK Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
5.1.5 UK Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
5.2 UK Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
5.3 UK Cancer Monoclonal Antibodies Sales and Market Share by Type
5.4 UK Cancer Monoclonal Antibodies Sales and Market Share by Application

6 Russia Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
6.1 Russia Cancer Monoclonal Antibodies Sales and Value (2012-2017)
6.1.1 Russia Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
6.1.2 Russia Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
6.1.6 Russia Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
6.2 Russia Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
6.3 Russia Cancer Monoclonal Antibodies Sales and Market Share by Type
6.4 Russia Cancer Monoclonal Antibodies Sales and Market Share by Application

7 Italy Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
7.1 Italy Cancer Monoclonal Antibodies Sales and Value (2012-2017)
7.1.1 Italy Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
7.1.2 Italy Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
7.1.7 Italy Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
7.2 Italy Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
7.3 Italy Cancer Monoclonal Antibodies Sales and Market Share by Type
7.4 Italy Cancer Monoclonal Antibodies Sales and Market Share by Application

8 Spain Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
8.1 Spain Cancer Monoclonal Antibodies Sales and Value (2012-2017)
8.1.1 Spain Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
8.1.2 Spain Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
8.1.8 Spain Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
8.2 Spain Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
8.3 Spain Cancer Monoclonal Antibodies Sales and Market Share by Type
8.4 Spain Cancer Monoclonal Antibodies Sales and Market Share by Application

9 Benelux Cancer Monoclonal Antibodies (Volume, Value and Sales Price)
9.1 Benelux Cancer Monoclonal Antibodies Sales and Value (2012-2017)
9.1.1 Benelux Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
9.1.2 Benelux Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
9.2 Benelux Cancer Monoclonal Antibodies Sales and Market Share by Manufacturers
9.3 Benelux Cancer Monoclonal Antibodies Sales and Market Share by Type
9.4 Benelux Cancer Monoclonal Antibodies Sales and Market Share by Application

10 Europe Cancer Monoclonal Antibodies Manufacturers Analysis
10.1 F. Hoffmann-La Roche
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Amgen
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Amgen Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Bristol-Myers Squibb
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Takeda Pharmaceuticals
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 AstraZeneca
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 AstraZeneca Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Bayer
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Bayer Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Merck
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Merck Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Janssen Biotech
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Janssen Biotech Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Novartis
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Novartis Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 OncoMed Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Pfizer
10.12 Eli Lilly
10.13 Sanofi
10.14 TG Therapeutics
10.15 CTI BioPharma
10.16 Intas Pharmaceuticals
10.17 Boehringer Ingelheim
10.18 Biogen

11 Cancer Monoclonal Antibodies Manufacturing Cost Analysis
11.1 Cancer Monoclonal Antibodies Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Monoclonal Antibodies Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Cancer Monoclonal Antibodies Market Forecast (2017-2022)
14.1 Germany Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.2 France Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.3 UK Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.4 Russia Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.5 Italy Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.6 Spain Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.7 Benelux Cancer Monoclonal Antibodies Sales Forecast (2017-2022)
14.8 Europe Cancer Monoclonal Antibodies Sales Forecast by Type (2017-2022)
14.9 Europe Cancer Monoclonal Antibodies Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Cancer Monoclonal Antibodies
Table Classification of Cancer Monoclonal Antibodies
Figure Europe Sales Market Share of Cancer Monoclonal Antibodies by Type in 2015
Figure Naked MAbs Picture
Figure Conjugated MAbs Picture
Table Application of Cancer Monoclonal Antibodies
Figure Europe Sales Market Share of Cancer Monoclonal Antibodies by Application in 2015
Figure Immune System Suppressors Examples
Figure Kill or Inhibit Malignant Cells Examples
Figure Deliver Chemotherapy To Cancer Cells Examples
Figure Germany Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure France Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure UK Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Russia Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Italy Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Spain Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Benelux Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Figure Europe Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2022)
Figure Europe Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Table Europe Cancer Monoclonal Antibodies Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Monoclonal Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Monoclonal Antibodies Sales Share by Manufacturers
Figure 2016 Cancer Monoclonal Antibodies Sales Share by Manufacturers
Table Europe Cancer Monoclonal Antibodies Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 Europe Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table Europe Cancer Monoclonal Antibodies Sales and Market Share by Type (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Sales Growth Rate by Type (2012-2017)
Table Europe Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
Table Europe Cancer Monoclonal Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Revenue Growth Rate by Type (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales and Market Share by Countries (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Share by Countries (2012-2017)
Figure Sales Market Share of Cancer Monoclonal Antibodies by Countries (2012-2017)
Table Europe Cancer Monoclonal Antibodies Revenue and Market Share by Countries (2012-2017)
Table Europe Cancer Monoclonal Antibodies Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by Countries (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales and Market Share by Application (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Monoclonal Antibodies by Application (2012-2017)
Figure Germany Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Germany Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Germany Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Germany Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Germany Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Germany Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Germany Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure France Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure France Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure France Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table France Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table France Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table France Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table France Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table France Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table France Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure UK Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure UK Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure UK Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table UK Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table UK Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table UK Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table UK Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table UK Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Russia Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Russia Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Russia Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Russia Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Russia Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Russia Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Russia Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Italy Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Italy Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Italy Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Italy Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Italy Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Italy Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Italy Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Spain Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Spain Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Spain Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Spain Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Spain Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Spain Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Spain Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Benelux Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
Figure Benelux Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
Figure Benelux Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
Table Benelux Cancer Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Benelux Cancer Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Benelux Cancer Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Benelux Cancer Monoclonal Antibodies Market Share by Application (2015 and 2016)
Table Cancer Monoclonal Antibodies Basic Information List
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Biotech Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table OncoMed Pharmaceuticals Basic Information List
Table OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Eli Lilly Basic Information List
Table Sanofi Basic Information List
Table TG Therapeutics Basic Information List
Table CTI BioPharma Basic Information List
Table Intas Pharmaceuticals Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Biogen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Monoclonal Antibodies
Figure Manufacturing Process Analysis of Cancer Monoclonal Antibodies
Figure Cancer Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Cancer Monoclonal Antibodies
Table Distributors/Traders List
Figure Germany Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure Germany Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure France Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure France Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure UK Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure UK Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure Russia Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure Italy Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure Spain Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Cancer Monoclonal Antibodies Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Table Europe Cancer Monoclonal Antibodies Sales Forecast by Type (2017-2022)
Table Europe Cancer Monoclonal Antibodies Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *